Showing results (1081-1090 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|August 8, 2023
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?Cecilia Maria Esposito, Jennifer L Barkin, Alessandro Ceresa, et al.International Clinical Psychopharmacology|September 28, 2023
Neuropsychiatric symptoms in a patient under cystic fibrosis transmembrane conductance regulator modulators treatment: a case reportHelena Andreu, Luis Olivier, Anna Giménez-Palomo, et al.International Clinical Psychopharmacology|September 20, 2023
Catatonic postpartum paternal depression as a first debut of a bipolar disorder: a case reportOscar de Juan, Albert Mas, Anna Giménez-Palomo, et al.International Clinical Psychopharmacology|June 23, 2023
Sex-specific clinical characteristics and treatment responses in delirium management: findings from a prospective cohort study in elderly patientsFlorian F Hildenbrand, Soenke Boettger, Tobias Spiller, et al.International Clinical Psychopharmacology|June 23, 2023
Temperament and character dimensions explain self-reported resilience deficits in patients with affective disordersEvdoxia Tsigkaropoulou, Ioannis Michopoulos, Evgenia Porichi, et al.International Clinical Psychopharmacology|June 23, 2023
The Gordian knot of the immune-redox systems' interactions in psychosisEvangelos KaranikasInternational Clinical Psychopharmacology|November 1, 2002
Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxineP H Silverstone, R Entsuah, D HackettInternational Clinical Psychopharmacology|November 1, 2002
Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugsJ L Carrasco, M Gutiérrez, J C Gómez, et al.International Clinical Psychopharmacology|November 1, 2002
Mirtazapine in social anxiety disorder: a pilot studyJ F Van Veen, I M Van Vliet, H G M WestenbergInternational Clinical Psychopharmacology|December 20, 2002
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemideStefano Pini, Xavier F Amador, Liliana Dell'Osso, et al.Pageof 212